ICAM1-Targeting Theranostic Nanoparticles for Magnetic Resonance Imaging and Therapy of Triple-Negative Breast Cancer

PURPOSE: Owing to the lack of effective biomarkers, triple-negative breast cancer (TNBC) has the worst prognosis among all subtypes of breast cancer. Meanwhile, tremendous progress has been made to identify biomarkers for TNBC. However, limited number of biomarkers still restrain the specifically ta...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Jieying, Lv, Mingchen, Su, Xiaolian, Wang, Sizhu, Wang, Yitong, Fan, Zhen, Zhang, Lin, Tang, Guangyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9700474/
https://www.ncbi.nlm.nih.gov/pubmed/36444196
http://dx.doi.org/10.2147/IJN.S374293

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9700474/
https://www.ncbi.nlm.nih.gov/pubmed/36444196
http://dx.doi.org/10.2147/IJN.S374293

Ejemplares similares